Interprofessional Care of Patients with Pruritus Associated with Primary Biliary Cholangitis

To participate in this activity, please:

Log in Sign Up

Pruritus is a common, often debilitating symptom experienced by patients with primary biliary cholangitis (PBC) that, along with other symptoms and disease complications, is best managed by an interprofessional, multidisciplinary care team. This activity highlights key concepts in patient management, as well as provides an overview of the principles of interprofessional collaboration and describes recommended roles for each member of the interprofessional liver care team.

Course Credit:

0.25 AAPA Category I CME Credit
0.25 ACPE Contact Hours
0.25 AMA PRA Category 1 CreditsTM
0.25 ANCC Contact Hours
0.25 CA-BRN Contact Hours

Dates:

Opens: 2025-11-26
Closes: 2026-11-26

Target Audience:

Nurse practitioners, pharmacists, physician associates, and physicians who provide care to patients with primary biliary cholangitis

This activity was self-funded by Annenberg Center for Health Sciences.

Accreditation Information

Accreditation

In support of improving patient care, the Annenberg Center for Health Sciences at Eisenhower (Annenberg Center) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Annenberg Center for Health Sciences at Eisenhower designates this knowledge-based activity for a maximum of 0.25 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

The Annenberg Center has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 hours AAPA Category 1 CME credits. Approval is valid until November 26, 2026. Physician Associates should only claim credit commensurate with the extent of their participation.

Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 0.25 ANCC contact hours.

Provider is approved by the California Board of Registered Nursing, Provider #13664, for 0.25 contact hours.
To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.
This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.

Additional Content Planners

Lori M. Dickerson, PharmD, FCCP (Planner)
No significant relationships to disclose.

Tim Drake, PharmD, MBA, BCPS (Planner)
No significant relationships to disclose.

Melissa Ketchum, CHCP (Planner)
No significant relationships to disclose.

Gregory Scott, PharmD, RPh (Planner)
No significant relationships to disclose.

All of the financial relationships listed for these individuals have been mitigated.

    Contributing Faculty

  • Alan Bonder, MD

    Medical Director of Liver Transplant
    Beth Israel Deaconess Medical Center
    Associate Professor of Medicine
    Harvard Medical School
    Boston, Massachusetts

  • Christopher Flores, MD

    Family Medicine Physician
    Eisenhower Medical Center
    Rancho Mirage, California

  • Kris Kowdley, MD

    Director, Liver Institute Northwest
    Medical Director and Senior Scientific Advisor, Velocity Clinical Research
    Professor, Elson S. Floyd College of Medicine
    Washington State University
    Seattle, Washington

  • LaTosha Mollette, DNP

    Family Nurse Practitioner
    Louisiana Family Medicine Clinic
    Jonesboro, Louisiana

  • Michael Smith, PharmD

    Clinical Pharmacist in Pain/Palliative Care
    University of Michigan
    Ann Arbor, Michigan

Learning Objectives

  • Describe the evolution in the treatment landscape for patients with pruritus associated with primary biliary cholangitis.
  • Identify strategies to improve interprofessional care of patients with pruritus associated with primary biliary cholangitis.

Faculty Disclosures

Alan Bonder, MD

Consultant: Alfasigma, Alnylam, Chemomab, CymaBay, GSK, Guidepoint; Intercept, Ipsen

Medical Reviewer: Pfizer

Research Support: Alfasigma, Alnylam, Chemomab, CymaBay, GSK, Intercept, Ipsen, Mirum


Christopher Flores, MD

No relationships to disclose.

Kris Kowdley, MD

Advisory Board: Medpace, MSD

Consultant: 89bio, Arbormed, Boehringer Ingelheim CymaBay, Genfit, Gilead, GSK, HighTide, Inipharm, Intercept, Ipsen, Madrigal, Mirum, NGM, Novo Nordisk, Orphalan, Pfizer, Zydus

Speakers Bureau: AbbVie, Gilead, Intercept, Ipsen

Stock: Inipharm


LaTosha Mollette, DNP

No relationships to disclose.

Michael Smith, PharmD

No relationships to disclose.